[Latest News][6]

Best Stock Advisory Company in Indore
Commodity Market Tips
Commodity Tips
Gold
Indian Stock Market Tips
Market
MCX Tips
NCDEX tips
Nifty Future Tips
NSE BSE
NSE BSE stock
NSE BSE stock Market
Share Market Tips
Silver
Stock Market Tips

Indian drug for dementia gets US regulatory nod

Indian drug-maker Strides Shasun Ltd has got approval of the US regulator for its Memantine Hydrochloride tablets to treat Alzheimer's-type dementia, said the company on Wednesday. In a regultory filing on the BSE, the city-based company said the US Food & Drug Administration (USFDA) has approved its 5mg and 10mg Memantine Hydrochloride tablets for treating moderate to severe Alzheimer's-type dementia. "The US market for Memantine Hydrochloride tablets is about $60 million. The product will be manufactured at our flagship facility in Bengaluru and marketed by Strides Pharma Inc in the US at the earliest,".

Get profit from the Financial Market with lots of profitable service packages and more click here--- http://www.ripplesadvisory.com/nifty-future-.php

No comments:

Post a Comment

Note: only a member of this blog may post a comment.

Start typing and press Enter to search